Please select


For My Business

< R10m annual turnover

For My Business

> R10m annual turnover

Please select


For My Business

< R10m annual turnover

For My Business

> R10m annual turnover

Switch to FNB Business

Product shop

By Turnover

First Business Zero (R0 - R5 million p.a) Gold Business (R0 - R5 million p.a) Platinum Business (R5 million - R60 million p.a) Enterprise Business (R60 million - R150 million+ p.a)

Transact

Business Accounts Credit Cards Cash Solutions Merchant Services eWallet Pro Staffing Solutions ATM Solutions Ways to bank Fleet Services Guarantees

Savings and Investments

Save and Invest 3PIM (3rd Party Investment Manager)

Borrow

FNB Cash Advance Overdraft Loans Debtor Finance Leveraged Finance Private Equity Securities Based Lending Selective Invoice Discounting Asset Based Finance Alternative Energy Solutions Commercial Property Finance Fleet Services

Insure

Insurance

For my employees

Staffing Solutions Employee benefits

Forex + Trade

Foreign Exchange Imports and exports Structured Trade + Commodity Finance Business Global Account (CFC account)

Value Adds + Rewards

Connect my business the dti initiatives Enterprise and supplier development Business Hub eBucks Rewards for Business DocTrail™ CIPC Integration Channel Instant Accounting Solutions Instant Payroll Instant Cashflow Instant Invoicing SLOW 24/7 Business Desk FNB Business Fundaba nav» Marketplace Prepaid products Accounting integrations

Industry Expertise

Philanthropy Chinese Business Islamic Banking Agriculture Public Sector Education Healthcare Franchise Motor Dealership Tourism

Going Global

Global Commercial Banking

Financial Planning

Overview

Bank Better

KYC / FICA Debit order + recipient switching Electronic Alerts

Corporates + Public Sector

Corporate Public Sector

All savings + investment accounts


Cash deposits

Notice deposits Immediate access Access to a portion Fixed deposits

Share investing

Shares

Tax-free investing

Tax-free accounts

Funds/unit trusts

Ashburton specialised products

Invest abroad

Offshore products

I want to save for

Personal goals Child's education Emergencies Tax-free

Compare similar

Compare

Additional options

Show me all Help me chosse Find an advisor

Financial planning

Overview

Back

Trade Ideas

Local Trade Idea: Dis-Chem Pharmacies (DCP) - BUY

 

Peet Serfontein & Jalpa Bhoolia.

Dis-Chem is one of the leading pharmaceutical and consumer wellness groups in South Africa. Dis-Chem takes a 'Pharmacy First' approach, with the main aim of serving the primary pharmaceutical needs of individuals. Other products on offer include personal and beauty products, health, nutrition, and baby care products, as well as confectionery, dry grocery, household and other ancillary goods. The group utilises its wholesale business to service third parties and Dis-Chem retail pharmacies through its CJ distribution business.

Dis-Chem is the market leader in dispensary, and we are positive on the growth prospects of this space.

Technically, a share that displays seasonal patterns makes for an interesting investment opportunity (see the insert).

These patterns, often rooted in historical data, can offer insights into future market movements. Additionally, this approach leverages recurring temporal shifts in market dynamics. Transitioning into autumn (current), historical data since November 2016 shows an encouraging average return of +0.9%. Moving into winter (indicated by number 1 on the bar chart), the trend continues upward with a positive return of +3.1%. Momentum peaks in spring (referenced by number 2 on the bar), with an impressive return of +8.1%. Summer (indicated by number 3), however, stands out as the only season demonstrating negative performance in this cycle.

The share is in a "markup" phase according to the market cycle analysis. A "markup" phase sees a share (or the market as a whole) enter a bullish trend, following a period of accumulation where early investors have started to buy into the share at low prices.

According to the RSI (Relative Strength Index), the stock will be overbought at ~R35.00, which is the same level as our profit target.

We suggest a low capital at-risk allocation to this trade. Increase exposure for a break above R31.50.

Share Information

Share Code DCP
Industry Consumer Staples Distribution
Market Capital (ZAR) 26.43 billion
One Year Total Return 15.64%
Return Year-to-Date 0.13%
Current Price (ZAR) 30.73
52 Week High (ZAR) 31.20
52 Week Low (ZAR) 21.54
Financial Year End February
The share has made good progress over a one-year period, and technical indicators are supportive of further upside. The share price remains above its 200-day simple moving average of ~R26.15. Expect moderate volatility in the share price.

Consensus expectations

(Bloomberg)

FY23 FY24E FY25E FY26E
Headline Earnings per Share (ZAR) 1.16 1.14 1.42 1.68
Growth (%) -2.32 24.91 18.32
Dividend Per Share (ZAR) 0.47 0.45 0.58 0.69
Growth (%) -3.43 28.89 19.48
Forward PE (times) 27.05 21.66 18.30
Forward Dividend Yield (%) 1.46 1.89 2.26
Earnings are expected to have been under pressure in FY24 (ended February), but a rebound is anticipated over FY25 and FY26.

Buy/Sell Rationale

Technical Analysis:

  • The lower panel shows occurrences of the Three Outside Up Japanese candlestick pattern - indicated by a reading of 1. The pattern is regarded as a bullish signal, suggesting a potential reversal from a downtrend to an uptrend.
  • There are three candlesticks in the pattern. The first candle is a bearish candle that is part of a prevailing downtrend, indicating that sellers are in control. The second candle is bullish, and completely engulfs the first candle. This suggests strong buying pressure has overcome selling pressure, hinting at a change in market sentiment. The final candle is also bullish, and closes higher than the second candle, confirming the reversal and indicating continued buying interest.
  • The recent steep upward trajectory of the on-balance volume (OBV) indicator indicates that money is flowing into the share.
  • Fading upside price momentum according the MACD (Moving Average Convergence Divergence) histogram is slightly concerning.
  • The RSI is in oversold territory when the reading is below 30 and overbought when the reading is above 70. The current reading of the RSI is 61, leaving some room to the upside.
  • Our entry range is between R28.80 to R31.50. Our upside target is set at R35 (+13.4% from current levels).
  • Our proposed time to exit is end-May 2024. Keep the option open to close the trade if the price reaches our profit target in a shorter time.
  • A drop below R29 (~5.6% below current levels) is a concern for downside potential. As such, a stop-loss is recommended at this level.

Fundamental view:

  • We are positive on the health and beauty retail space in the South African context. Within this area, the company is the market leader in Dispensary, Vitamins and Supplements and Healthcare and Nutrition.
  • Private label accounts for a big portion of sales, with the possibility of increasing over time - these products tend to carry higher margins.
  • Dis-Chem's franchise model, The Local Choice, is an interesting differentiator for the business and is growing quickly. This business will drive supply chain volumes, and perhaps margins, in CJ distribution. Through this partner model it may also provide the larger group with opportunities to absorb once-independent pharmacies.
  • At the end of February, Dis-chem released a trading update for the period 1 September 2023 to 28 January 2024. The group said it was on track to finish the financial year ended February on a strong note - top-line growth was tracking very well ahead of consensus and momentum had picked up since the half-year point. Dis-Chem benefitted from strong festive season trade (a similar experience to sector peers). Retail revenue accelerated, while wholesale revenue softened a touch, but growth in external customers was impressive.
  • Progress around the group's strategic initiatives is encouraging and benefits are paying off, with momentum expected to pick up over FY25 to the aide of margins.
  • Risks to our fundamental view include bumpy store-rollouts (revenue growth could be lower compared to current market assumptions). Cannibalisation and persistent competition are also a key risk. Finally, Dis-Chem has always been a closely held, "family run" business and the transition post-Saltzman's exit could be challenging.

Share Name and position WHL - Stop-loss
(Close the position)
MRP - BUY
(Continue to hold)
APN - BUY
(Continue to hold)
Entry 68.03 157.50 182.66
Current 63.29 170.01 196.73
Movement -7% 7.9% 7.7%
A stop-loss was triggered, and we closed the position. Strong downside price momentum remains a concern. A price coinciding with a trough in the business cycle remains of interest. Fading upside momentum is concerning. Trading above its 200-day simple moving average.

Our take profit target remains at R213 with a trailing stop-loss level at R147.60. Exit the trade on 7 April 2025.
A developing symmetrical triangle pattern remains of interest. Trades above its 200-day simple moving average. Downside momentum is concerning.

Our profit target is R222, with a trailing stop-loss at R172. Exit the trade on 27 December 2024.

Share Name and position RDF - BUY
(Continue to hold)
SNT - BUY
(Continue to hold)
BTI - BUY
(Continue to hold)
Entry 3.78 296.56 562.87
Current 3.99 304.33 574.75
Movement 5.6% 2.6% 0.6%
A strategic investment opportunity. Continues to stay above its 200-day simple moving average. Fading upside momentum is concerning.

Our take profit target remains at R4.50 with a trailing stop-loss level at R3.75. Exit the trade on 4 March 2024.
An incomplete cup and saucer pattern remains of interest. Upside price momentum is a highlight. Remains above its 200-day simple moving average.

Our take profit target remains at R337 with a trailing stop-loss level at R288. Exit the trade on 29 April 2024.
A price that is testing the lower range of an inclining channel pattern remains of interest. Fading upside momentum is a concern. Trading below its 200-day simple moving average.

Our take profit target remains at R645 with a trailing stop-loss level at R542. Exit the trade on 22 April 2024.

How would you like to log in?